Published in J Clin Pathol on April 01, 1975
Acute marrow folate deficiency during intensive care. Br Med J (1978) 0.92
Letter: Unusual megaloblastic anaemia. J Clin Pathol (1975) 0.88
Problems in the diagnosis and investigation of megaloblastic anemia. Can Med Assoc J (1980) 0.85
Letter: Folic acid deficiency during intensive therapy. Br Med J (1976) 0.75
Severe thrombocytopenia associated with acute folic acid deficiency and severe hemorrhage in two patients. Can Med Assoc J (1984) 0.75
Dyserythropoiesis and dyserythropoietic anemias. Prog Hematol (1973) 1.16
Dysplastic anaemias. Nouv Rev Fr Hematol (1973) 1.13
[Refractory anemias: acquired enzymopathies of hematopoietic stem cells]. Nouv Rev Fr Hematol (1969) 1.08
Multipolar giant erythroblastosis; a second observation. Rev Belg Pathol Med Exp (1955) 1.05
A study of proximal and distal intestinal structure and absorptive function in idiopathic steatorrhoea. Q J Med (1967) 4.68
Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol (1991) 4.61
The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol (1996) 4.45
Method of assay of red cell folate activity and the value of the assay as a test for folate deficiency. J Clin Pathol (1966) 4.44
Tissue antibodies in dermatitis herpetiformis and adult coeliac disease. Lancet (1971) 3.50
Small-intestinal structure and function and haematological changes in dermatitis herpetiformis. Lancet (1967) 3.11
Circulating immune complexes in dermatitis herpetiformis. Lancet (1973) 2.78
Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses. J Exp Med (1988) 2.73
Anti-reticulin antibodies in childhood coeliac disease. Lancet (1971) 2.54
The complement abnormalities of lipodystrophy. N Engl J Med (1976) 2.40
Human cytomegalovirus-specific cytotoxic T lymphocytes: requirements for in vitro generation and specificity. Eur J Immunol (1983) 2.34
Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J Virol (1994) 2.31
Efficacy and possible adverse effects of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in thalassemia major. Blood (1992) 2.29
Folic acid fortification and cancer risk. Lancet (2007) 2.17
Antireticulin antibody: incidence and diagnostic significance. Gut (1973) 2.15
Human cytomegalovirus-specific cytotoxic T cells: their precursor frequency and stage specificity. Eur J Immunol (1988) 2.13
Lymphocytic infiltration of epithelium in diagnosis of gluten-sensitive enteropathy. Br Med J (1972) 2.11
Effect of gluten-free diet on dermatological, intestinal, and haematological manifestations of dermatitis herpetiformis. Lancet (1968) 2.09
Glomerular deposition of properdin in Henoch-Schönlein syndrome and idiopathic focal nephritis. Br Med J (1973) 2.07
Clearance of skin lesions in dermatitis herpetiformis after gluten withdrawal. Lancet (1973) 2.01
Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. Lancet (1982) 2.01
Mesangiocapillary nephritis, partial lipodystrophy, and hypocomplementaemia. Lancet (1973) 2.00
Parenteral acyclovir therapy for herpesvirus infections in man. Lancet (1979) 1.99
The human thymic microenvironment: an immunohistologic study. J Immunol (1980) 1.94
Combined therapy with deferiprone and desferrioxamine. Br J Haematol (1998) 1.91
Agranulocytosis and thrombocytopenia in patient with Blackfan-Diamond anaemia during oral chelator trial. Lancet (1989) 1.91
Folate deficiency and neurological disease. Lancet (1965) 1.85
Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol (1996) 1.82
Subcutaneous infusion and intramuscular injection of desferrioxamine in patients with transfusional iron overload. Lancet (1976) 1.81
Hypoparathyroidism and hypocalcaemia during treatment for acute leukaemia. Br Med J (Clin Res Ed) (1982) 1.72
Human virus-specific CD8+ CTL clones revert from CD45ROhigh to CD45RAhigh in vivo: CD45RAhighCD8+ T cells comprise both naive and memory cells. J Immunol (1999) 1.71
Improvement in iron status and liver function in patients with transfusional iron overload with long-term subcutaneous desferrioxamine. Lancet (1979) 1.70
The memory cytotoxic T-lymphocyte (CTL) response to human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo. J Virol (1999) 1.67
Fine specificity of cellular immune responses in humans to human cytomegalovirus immediate-early 1 protein. J Virol (1991) 1.62
Serum ferritin assay and iron status in chronic renal failure and haemodialysis. Br Med J (1975) 1.61
Gluten-free diet and reintroduction of gluten in dermatitis herpetiformis. Arch Dermatol (1969) 1.60
Deletion analysis of chromosome 13q14.3 and characterisation of an alternative splice form of LEU1 in B cell chronic lymphocytic leukemia. Leukemia (2002) 1.60
Bone-marrow aspiration and trephine biopsy (1). Br Med J (1980) 1.58
Mechanism of folate deficiency in patients receiving phenytoin. Lancet (1968) 1.58
Repression of human cytomegalovirus major immediate early gene expression in a monocytic cell line. J Gen Virol (1992) 1.57
Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia. Lancet (1982) 1.55
The hematologic complications following partial gastrectomy. A study of 292 patients. Am J Med (1967) 1.55
The small intestine in dermatitis herpetiformis. J Clin Pathol (1974) 1.54
Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol (2000) 1.54
Immunoglobulins in the skin in dermatitis herpetiformis and coeliac disease. Lancet (1972) 1.53
Human CD28-CD8+ T cells contain greatly expanded functional virus-specific memory CTL clones. J Immunol (1999) 1.50
Subpopulations of normal and leukemic human thymocytes: an analysis with the use of monoclonal antibodies. J Natl Cancer Inst (1980) 1.50
Antibody-independent activation of the alternative complement pathway by measles virus-infected cells. Proc Natl Acad Sci U S A (1980) 1.48
The immunogloblin nature of nephritic factor (NeF). Clin Exp Immunol (1978) 1.47
Controlled trial of a carbenoxolone/alginate antacid combination in reflux oesophagitis. Curr Med Res Opin (1978) 1.46
Increased numbers of cells with suppressor T cell phenotype in the peripheral blood of patients with infectious mononucleosis. Clin Exp Immunol (1981) 1.45
Multiple immune complexes and hypocomplementaemia in dermatitis herpetiformis and coeliac disease. Lancet (1976) 1.45
The transcription factor YY1 binds to negative regulatory elements in the human cytomegalovirus major immediate early enhancer/promoter and mediates repression in non-permissive cells. Nucleic Acids Res (1994) 1.44
Iron chelation therapy: the need for orally active drugs. J Lab Clin Med (1998) 1.42
Serum immunoreactive trypsin in beta-thalassaemia major. J Clin Pathol (1981) 1.41
Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue. J Immunol (1985) 1.41
Repression of human cytomegalovirus gene expression associated with a novel immediate early regulatory region binding factor. Nucleic Acids Res (1989) 1.40
Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients. Clin Infect Dis (1992) 1.39
A mechanism of migration inhibition in delayed-type hypersensitivity reactions. I. Fibrin deposition on the surface of elicited peritoneal macrophages on vivo. J Immunol (1981) 1.38
Large clonal expansions of human virus-specific memory cytotoxic T lymphocytes within the CD57+ CD28- CD8+ T-cell population. Immunology (1999) 1.37
Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial. Br Med J (Clin Res Ed) (1983) 1.37
Peripheral hyaline blebs (podosomes) of macrophages. J Cell Biol (1977) 1.35
Absorption of crystalline folic acid in man. Lancet (1968) 1.35
Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet (1988) 1.35
Folate deficiency in Crohn's disease: incidence, pathogenesis, and treatment. Br Med J (1968) 1.34
Multiparameter studies in lymphoid leukemias. Am J Clin Pathol (1979) 1.34
Antibody-mediated destruction of virus-infected cells. Adv Immunol (1980) 1.34
Iron and folate metabolism in tuberculosis. Br Med J (1966) 1.33
Folate deficiency in premature infants. Arch Dis Child (1970) 1.33
Orally active alpha-ketohydroxy pyridine iron chelators intended for clinical use: in vivo studies in rabbits. Br J Haematol (1986) 1.31
High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation. Acta Haematol (1990) 1.30
Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells. Br J Haematol (1976) 1.30
Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow. Lancet (1986) 1.29
Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemia. Lancet (1980) 1.29
Streptococcus mitis and ARDS in neutropenic patients. Lancet (1991) 1.28
Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one. Br Med J (Clin Res Ed) (1987) 1.28
Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside. Br J Haematol (1974) 1.28
Polymorphonuclear cells are not sites of persistence of human cytomegalovirus in healthy individuals. J Gen Virol (1993) 1.26
Splenic atrophy in dermatitis herpetiformis. Br Med J (1972) 1.25
Monocyte-derived inhibitor of interleukin 1 induced by human cytomegalovirus. J Virol (1985) 1.25
Studies of folate uptake by phytohaemagglutinin-stimulated lymphocytes. Br J Haematol (1970) 1.25
The 21bp repeat element of the human cytomegalovirus major immediate early enhancer is a negative regulator of gene expression in undifferentiated cells. Nucleic Acids Res (1991) 1.23
Comparison of three methods for measuring vitamin B 12 in serum: radioisotopic, euglena gracilis and Lactobacillus leichmannii. Br J Haematol (1972) 1.23
Indices of granulocyte activity in inflammatory bowel disease. Gut (1974) 1.21
Isolated glomerulonephritis with mesangial IgA deposits. Br Med J (1975) 1.20
Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J Exp Med (1993) 1.20
Alternate-pathway complement fixation by IgA in the skin in dermatitis herpetiformis. Lancet (1973) 1.20
Varicella-zoster virus-specific cytotoxic T lymphocytes (Tc): detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood. J Virol (1987) 1.20
Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. Clin Infect Dis (1993) 1.19
1,2-Dimethyl-3-hydroxypyrid-4-one, an orally active chelator for treatment of iron overload. Lancet (1987) 1.19
Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine. J Clin Pathol (1987) 1.17
High prevalence of low bone mass in thalassaemia major. Br J Haematol (1998) 1.15
Development of pluripotent hematopoietic progenitor cells in the human fetus. Blood (1983) 1.15
Effect of ascorbic acid deficiency on serum ferritin concentration in patients with beta-thalassaemia major and iron overload. J Clin Pathol (1982) 1.14
Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis. Br J Haematol (1999) 1.13
In vitro generation of human cytotoxic lymphocytes by virus. Viral glycoproteins induce nonspecific cell-mediated cytotoxicity without release of interferon. J Exp Med (1981) 1.13
Absorption of vitamin B 12 by the guinea-pig. I. Subcellular localization of vitamin B 12 in the ileal enterocyte during absorption. Br J Haematol (1970) 1.13